Insider · CIK 0001853985
Faith L. Charles
Files at ABEO (ABEONA THERAPEUTICS INC.), CDT (CDT Equity Inc.). First filing Jul 10, 2025, latest Jul 10, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ABEO: ABEONA THERAPEUTICS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | ABEONA THERAPEUTICS INC. | $63k 10,738 shares | -7% | +39% from low-15% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 9, 2025 | ABEO ABEONA THERAPEUTICS INC. | SOpen-market sale Common Stock | -10,738 | $5.86 | $63k | 139,094 | Jul 10, 2025 |
| Apr 16, 2025 | CDT CDT Equity Inc. | AGrant or award Common Stock | +115,194 | $0.87 | $100k | 165,238 | Apr 17, 2025 |
| Mar 30, 2025 | CDT CDT Equity Inc. | AGrant or award Common Stock | +46,629 | $0.89 | $41k | 50,044 | Apr 1, 2025 |
| Jan 31, 2025 | ABEO ABEONA THERAPEUTICS INC. | AGrant or award Common Stock | +36,101 | $0.00 | $0 | 149,832 | Feb 3, 2025 |
| Dec 18, 2024 | CDT CDT Equity Inc. | AGrant or award Stock Option (Right to Buy)derivative | +420,000 | $0.07 | $30k | 420,000 | Dec 20, 2024 |
| Nov 18, 2024 | CDT CDT Equity Inc. | AGrant or award Common Stock | +75,000 | - | - | 75,000 | Nov 20, 2024 |
| Nov 18, 2024 | CDT CDT Equity Inc. | AGrant or award Common Stock | +266,594 | $0.09 | $24k | 341,594 | Nov 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.